425: Arcadia Biosciences Q2 2025: Revenue Up, Net Loss Widens

Arcadia Biosciences reported an 11% increase in second-quarter 2025 revenues, primarily driven by Zola coconut water sales, but recorded a significant net loss due to a $4.5 million credit loss on a note receivable and the absence of prior year gains.

Summary

• Total revenues for the second quarter of 2025 increased 11% year-over-year to $1.455 million.
• Zola coconut water revenues grew 24% in the second quarter of 2025, outperforming its category.
• Gross margins exceeded 30% for ten consecutive quarters.
• Underlying operating expenses remained low, despite $700,000 in transaction fees.
• Received 2.7 million shares of Above Food Ingredients Inc. stock as partial repayment of a $6 million note receivable.
• Eliminated $1 million in contingent liabilities from an agreement with Bioseed Research India, bringing year-to-date liability elimination to $2 million.
• Net loss attributable to common stockholders for the second quarter of 2025 was $4.5 million ($3.26 per share), a $5.5 million reduction from the second quarter of 2024 net income.
• Recognized a $4.5 million credit loss related to the Above Food note receivable due to an unpaid principal and interest payment due May 14, 2025.
• The business combination with Roosevelt Resources is progressing, with an amended Form S-4 registration statement filed on July 31, 2025.

Sentiment

Score: 4

Explanation: While revenue growth, particularly for Zola, and the elimination of liabilities are positive, these are significantly overshadowed by a substantial net loss and a large credit loss from an unpaid note receivable. The ongoing merger introduces both potential upside and considerable risks, leading to a cautious outlook.

Positives

• Total revenues increased 11% year-over-year in Q2 2025 to $1.455 million.
• Zola coconut water revenues grew 24% in Q2 2025, surpassing category performance.
• Gross margins consistently exceeded 30% for ten straight quarters.
• Underlying operating expenses remained low.
• Received 2.7 million shares of Above Food Ingredients Inc. stock as partial repayment of a note receivable.
• Eliminated $1 million in contingent liabilities in Q2 2025, totaling $2 million year-to-date.

Negatives

• Net loss attributable to common stockholders for Q2 2025 was $4.5 million ($3.26 per share), a significant reduction from $1.1 million net income in Q2 2024.
• Recognized a $4.5 million credit loss related to the note receivable from Above Food Corp.
• The first payment of principal and accrued interest from Above Food Corp. was due May 14, 2025, and remained unpaid as of June 30, 2025.
• Total operating expenses increased significantly in Q2 2025 compared to Q2 2024, primarily due to the absence of a $4.0 million gain on sale of RS durum wheat patents recorded in Q2 2024.

Risks

• Risks and uncertainties that could cause actual results to differ materially, as set forth in SEC filings, including the Annual Report on Form 10-K and the Form S-4 registration statement.
• Ability to obtain sufficient funding required to continue operations and planned activities.
• Ability to obtain stockholder approvals required to complete the proposed business combination transaction with Roosevelt Resources.
• The occurrence of any event, change, or circumstance that could lead to the termination of the proposed business combination transaction.
• Uncertainty regarding the repayment of the remaining outstanding balance of the note receivable from Above Food Corp. and the issuance of approximately 800,000 remaining shares.

Future Outlook

The company's pending business combination with Roosevelt Resources is moving forward, with an amended Form S-4 registration statement filed. Arcadia intends to mail a definitive proxy statement/prospectus to stockholders after the Registration Statement is declared effective by the SEC, leading to a stockholder meeting to consider the proposed transaction. The company also continues to pursue repayment of the remaining outstanding balance of the note receivable from Above Food Corp.

Management Comments

• "We are very pleased with our performance for the second quarter of 2025." T.J. Schaefer, CEO
• "While our total revenues have increased 11% compared to the second quarter of 2024, Zola coconut water revenues have grown 24% and once again surpassed the performance of the category." T.J. Schaefer, CEO
• "Our gross margins have now exceeded 30% for ten straight quarters, while our underlying operating expenses remain low, even with almost $700,000 in transaction fees this quarter." T.J. Schaefer, CEO
• "In addition to our strong operating performance, we received 2.7 million shares of stock in Above Food Ingredients Inc. as a partial repayment of the $6 million principal amount of the note receivable related to the sale of GoodWheatTM assets in the second quarter of 2024, and we continue to pursue repayment of the remaining outstanding balance." T.J. Schaefer, CEO
• "We have also completed the exit from our legacy businesses following the agreement with Bioseed Research India, which resulted in the elimination of the remaining $1 million in contingent liabilities, bringing the total to $2 million of liabilities that have been eliminated year-to-date." T.J. Schaefer, CEO
• "Our pending business combination with Roosevelt Resources continues to move forward." T.J. Schaefer, CEO
• "We recently filed an amendment to the initial Form S-4 registration statement to provide responses to comments received from the SEC and to provide updated financial information through the first quarter of 2025 for both Arcadia Biosciences and Roosevelt Resources." T.J. Schaefer, CEO

Industry Context

Arcadia Biosciences operates in the wellness products sector, specifically with its Zola coconut water brand. The company's Zola revenues grew 24% in Q2 2025, indicating strong performance that surpassed the overall category growth, suggesting effective market penetration and consumer demand for its healthy ingredients.

Comparison to Industry Standards

• The filing states that Zola coconut water revenues grew 24% in Q2 2025, which "once again surpassed the performance of the category." However, no specific industry benchmarks, comparable companies, or detailed market data are provided within the filing to allow for a direct, specific assessment against global industry standards or competitors beyond this general statement.

Stakeholder Impact

• Shareholders: Will vote on the proposed all-stock business combination with Roosevelt Resources, which could impact ownership structure and future value. Experience significant net loss and a credit loss impacting company financials.
• Creditors: The company recognized a $4.5 million credit loss on a note receivable from Above Food Corp. due to non-payment, impacting the company's ability to collect on this debt.
• Customers: Zola coconut water sales are growing, indicating continued customer demand for this product.

Next Steps

• SEC to declare the Registration Statement on Form S-4 effective.
• Mailing of a definitive proxy statement/prospectus to Arcadia stockholders.
• Holding a meeting of stockholders to consider matters relating to the proposed transaction with Roosevelt Resources.
• Closing of the business combination transaction with Roosevelt Resources.
• Continued pursuit of repayment for the remaining outstanding balance of the note receivable from Above Food Corp. and the issuance of approximately 800,000 remaining shares.

Key Dates

Recommendation

The company exhibits mixed performance with strong revenue growth in its Zola brand and successful elimination of legacy liabilities. However, a significant net loss for the quarter, primarily driven by a substantial credit loss on a note receivable, raises concerns about asset quality and profitability. The pending all-stock merger with Roosevelt Resources presents a transformative event, but also introduces integration and execution risks. Investors should hold to monitor the successful completion of the merger and the resolution of the outstanding note receivable, as these factors will significantly influence future valuation.

Keywords

Arcadia Biosciences, RKDA, Roosevelt Resources, Merger, Financial Results, Q2 2025, Zola Coconut Water, Wellness Products, SEC Filing, Form 8-K, Credit Loss, Corporate Combination